Company intelligence / Profile preview
invoX Pharma
London, England, United Kingdominvoxpharma.com ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
01
Overview
The company has a diversified pipeline of promising clinical and pre-clinical stage drug candidates in respiratory therapeutics and oncology
- Therapeutic areas
- OncologyPulmonology
- Modalities
- Small moleculesbiologicals (peptides, nucleic acids, enzymes, antibodies)
- Industry
- Biotech
02
Drug pipeline
33 assets32 more assets in the full pipeline.
03
Partnerships
Insilico Medicine (AI collaboration announced April 2024)
Beyond the preview
Go deeper on invoX Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on invoX Pharma.